Viewing Study NCT01520103

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-03-06 @ 12:31 PM
Study NCT ID: NCT01520103
Status: COMPLETED
Last Update Posted: 2017-08-09
First Post: 2012-01-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Sponsor: AIO-Studien-gGmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Her2-negative Metastatic Breast Cancer View
None Her2-negative Locally Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic breast cancer View
None locally advanced breast cancer View
None Her2/new negative View
None HER2 negative View